About the Authors
- Cathie Sudlow
-
Affiliations University of Edinburgh, Edinburgh, United Kingdom, UK Biobank, Stockport, United Kingdom
- John Gallacher
-
Affiliation University of Cardiff, Cardiff, United Kingdom
- Naomi Allen
-
Affiliations UK Biobank, Stockport, United Kingdom, University of Oxford, Oxford, United Kingdom
- Valerie Beral
-
Affiliation University of Oxford, Oxford, United Kingdom
- Paul Burton
-
Affiliation University of Bristol, Bristol, United Kingdom
- John Danesh
-
Affiliation University of Cambridge, Cambridge, United Kingdom
- Paul Downey
-
Affiliation Imperial College, London, United Kingdom
- Paul Elliott
-
Affiliation Imperial College, London, United Kingdom
- Jane Green
-
Affiliation University of Oxford, Oxford, United Kingdom
- Martin Landray
-
Affiliation University of Oxford, Oxford, United Kingdom
- Bette Liu
-
Affiliation University of New South Wales, Sydney, Australia
- Paul Matthews
-
Affiliation Imperial College, London, United Kingdom
- Giok Ong
-
Affiliation University of Warwick, Warwick, United Kingdom
- Jill Pell
-
Affiliation University of Glasgow, Glasgow, United Kingdom
- Alan Silman
-
Affiliation University of Manchester, Manchester, United Kingdom
- Alan Young
-
Affiliation University of Oxford, Oxford, United Kingdom
- Tim Sprosen
-
Affiliation University of Oxford, Oxford, United Kingdom
- Tim Peakman
-
Affiliation UK Biobank, Stockport, United Kingdom
- Rory Collins
-
* E-mail: enquiries@ukbiobank.ac.uk
Affiliations UK Biobank, Stockport, United Kingdom, University of Oxford, Oxford, United Kingdom
Competing Interests
All authors are current or past members of UK Biobank’s executive management team or steering committee, or of one of UK Biobank’s working groups. PM is a part-time employee and holder of stock and options in GlaxoSmithKline and has received attendance fees and contributed to panels convened by the Medical Research Council, a public funder of UK Biobank. JD has received research funding from The Wellcome Trust, British Heart Foundation, UK Medical Research Council, BUPA Foundation, Denka, diaDexus, European Research Council, European Union, Evelyn Trust, Fogarty International Centre, GlaxoSmithKline, Merck, National Heart, Lung and Blood Institute, National Health Service Blood and Transplant, National Institute for Health Research, National Institute of Neurological Disorders and Stroke, Novartis, Pfizer, Roche, UK Biobank. RC is the CEO and PI of UK Biobank, which is a charity set up by the MRC and Wellcome Trust to establish this prospective cohort as a resource for researchers from around the world. RC is a member of the Editorial Board of PLOS Medicine. All other authors have declared that no competing interests exist.
Author Contributions
Wrote the first draft of the manuscript: CS JG NA GO RC. Contributed to the writing of the manuscript: CS JG NA VB PB JD PD PE JG ML BL PM GO JP AS AY TS TP RC. ICMJE criteria for authorship read and met: CS JG NA VB PB JD PD PE JG ML BL PM GO JP AS AY TS TP RC. Agree with manuscript results and conclusions: CS JG NA VB PB JD PD PE JG ML BL PM GO JP AS AY TS TP RC.